Prenatal Testing and Newborn Screening Market Revenue Poised for Significant Growth During the Forecast Period of 2020-2027
Growing prevalence of chromosome syndrome in babies is one of the significant factors influencing the market growth.
Prenatal Testing and Newborn Screening Market Size – USD 4,124.3 Million in 2019, Market Growth – CAGR of 12.8%, Market Trends –Rising demand for non-invasive techniques
The Global prenatal testing and newborn screening market Report offers extensive knowledge and information about the Prenatal Testing and Newborn Screening market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends. The report is formulated with the updated and latest information of the global Prenatal Testing and Newborn Screening market further validated and verified by the industry experts and professionals. The Global Prenatal Testing and Newborn Screening Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Prenatal Testing and Newborn Screening market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market.
Furthermore, the report is attuned with the latest market changes and economic landscape with regard to the currently unfolding COVID-19 pandemic. The crisis has affected the demand and supply pattern, as well as the trends of the industry. It has also brought an economic slowdown that has affected the business of the key manufacturers of the industry. The report estimates the impact of this crisis on the current scenario and future prospects and provides a post-COVID market scenario.
Key participants include Abbott Laboratories, Bio-Rad Laboratories, Color Genomics, Edinburgh Genomics, Eurofins Scientific, Agilent Technologies, CRISPR, Illumina Inc., Editas Medicine, and Qiagen NV, among others.
To know more about the report: https://www.emergenresearch.com/industry-report/prenatal-testing-and-newborn-screening-market
COVID-19 Impact Analysis:
This report is the latest document encompassing the massive changes that took place in the Prenatal Testing and Newborn Screening market following the emergence of the COVID-19 pandemic. The pandemic has drastically affected the global economic landscape, thereby disrupting the operating mechanism of the Prenatal Testing and Newborn Screening market. The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment. Therefore, the report fully covers the profound impact of COVID-19 on this industry, with a special focus on the affected industry segments. However, the market is expected to regain momentum in the post-COVID-19 era. The report also offers an initial and future impact assessment of the pandemic on the Prenatal Testing and Newborn Screening industry. Hence, the vital COVID-19 insights offered by the report are expected to help organizations manage their businesses effectively in extreme economic uncertainties.
The report further assesses the market dynamics, market landscape, company profiles, production and manufacturing capacity, year-on-year growth rate, SWOT analysis, and Porter’s Five Forces analysis. It offers in-depth assessment of key companies operating in the market on the basis of their expansion plans, market position, financial standing, and gross profit margins.
The prenatal testing and newborn screening market is observing high demand attributed to its increasing application in detecting fetal chromosome defects. Prenatal testing is considered superior to other screening modalities, particularly for trisomy 21 (one of the most prevalent congenital anomalies). Prenatal testing enables individuals to make informed decisions as to whether diagnostic testing should be carried out. Associated fetal chromosomal anomalies typically include the benefit or lack of genetic material that can differ from small segments to small segments of chromosomes to entire chromosomes.
The increasing popularity among pregnant women as an alternative to amniocentesis and awareness of genetic problems in the fetus and newborn babies drives prenatal testing and newborn screening market.In April 2019, Progenity Inc. made an announcement about the introduction of the Resura Prenatal Test, a non-invasive, personalized prenatal check for monogenetic diseases.Ultrasonography is projected to observe a significant growth rate in the forecast period, owing to the ability of the ultrasound diagnosis to detect anomalies in the position of the baby and actions within the womb.
The hospital held a substantial market share in 2019 due to the growing introduction of non-invasive prenatal testing, coupled with rapid technological developments in newborn screening, the presence of skilled professionals, and better reimbursement scenario.North America dominated the market for Prenatal Testing and Newborn Screening in 2019 due to the availability of technologically advanced healthcare research system and developments in whole-genome sequencing.
Get a sample of the report :https://www.emergenresearch.com/request-sample/346
Emergen Research has segmented the global prenatal testing and newborn screening market on the basis of type, test type, technology, instrument, end-users, and region:
Type Outlook (Revenue, USD Billion; 2017-2027)
- Prenatal Testing
- Newborn Screening
Test Type Outlook (Revenue, USD Billion; 2017-2027)
Technology Outlook (Revenue, USD Billion; 2017-2027)
- Mass Spectrometry
- Enzyme Immunoassays
- DNA Assays
Instrument Outlook (Revenue, USD Billion; 2017-2027)
- Reagent and Assay Kits
- Tandem Quadrupole Detector
- Incubator Shaker
- Hearing Screen Instruments
End Users Outlook (Revenue, USD Billion; 2017-2027)
- Maternity & Specialty Clinics
- Diagnostic Centers
Chapter 1: Methodology & Scope
- Definition and forecast parameters
- Methodology and forecast parameters
- Data Sources
- Business trends
- Regional trends
- Product trends
- End-use trends
- Industry segmentation
- Industry landscape
- Vendor matrix
- Technological and innovation landscape
- Business Overview
- Financial Data
- Product Landscape
- Strategic Outlook
Key Questions Answered in the Report:
What is the growth rate of the Prenatal Testing and Newborn Screening market? What is the anticipated market valuation of Prenatal Testing and Newborn Screening industry by 2027?
What are the key growth driving and restraining factors of the Prenatal Testing and Newborn Screening market?
Who are the prominent players operating in the market? What are the key strategies adopted by these companies?
What are the key opportunities and growth prospects of the Prenatal Testing and Newborn Screening industry over the forecast period?
Which region is expected to show significant growth in the coming years?
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request a discount on the report : https://www.emergenresearch.com/request-discount/346
Patient Engagement Solutions Market: https://www.emergenresearch.com/industry-report/patient-engagement-solutions-market
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market
Non-Invasive Prenatal Testing Market: https://www.emergenresearch.com/industry-report/non-invasive-prenatal-testing-market
RNA Transcriptomics Market: https://www.emergenresearch.com/industry-report/in-vitro-fertilization-market
Blockchain in Healthcare: Https://www.forbes.com/sites/forbestechcouncil/2021/12/07/four-key-medtech-software-development-trends-for-2022/?sh=23e843f420d5
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]